Ultracet is a brand name for a combination pain medication. The original manufacturer and innovator of Ultracet is Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson [1].
Who Else Sells Ultracet?
While Janssen Pharmaceuticals originally developed Ultracet, generic versions are now available from various pharmaceutical companies. These companies manufacture and market their own versions of the combination drug, often under different brand names or as generic Ultracet [2].
What Is Ultracet Used For?
Ultracet is prescribed to manage moderate to moderately severe pain [3]. It is a combination of two active ingredients: tramadol hydrochloride and acetaminophen [3]. Tramadol is an opioid analgesic, and acetaminophen is a non-opioid analgesic and antipyretic [3].
When Does Ultracet Go Off-Patent?
The patent protection for branded drugs like Ultracet has largely expired, allowing for the introduction of generic versions. The original patent expiry dates for the tramadol/acetaminophen combination have passed, making it eligible for generic competition [4]. DrugPatentWatch.com tracks these patent expiries and exclusivity periods for pharmaceuticals [4].
How Does Ultracet Compare to Other Pain Relievers?
Ultracet's efficacy and safety profile place it in a category of pain relievers that are stronger than over-the-counter options like ibuprofen or naproxen alone, but typically considered less potent than pure opioid analgesics. Its combination of an opioid and acetaminophen allows for a synergistic effect, potentially reducing the required dose of each component and mitigating some side effects [3].
What Are the Risks Associated with Ultracet?
As Ultracet contains tramadol, a controlled substance, it carries risks associated with opioid use. These include the potential for dependence, addiction, and overdose, especially when used at higher doses or for extended periods [3]. Side effects can also include dizziness, nausea, constipation, and drowsiness [3]. Acetaminophen, when taken in high doses, can cause liver damage [3].